EcoR1 Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,346,475
| Closed | -$21.9M | – | 64 |
|
|
2024
Q2 | $21.9M | Sell |
1,346,475
-4,645,004
| -78% | -$75.5M | 0.67% | 32 |
|
|
2024
Q1 | $111M | Hold |
5,991,479
| – | – | 2.8% | 12 |
|
|
2023
Q4 | $188M | Hold |
5,991,479
| – | – | 4.87% | 6 |
|
|
2023
Q3 | $125M | Hold |
5,991,479
| – | – | 4.21% | 7 |
|
|
2023
Q2 | $143M | Hold |
5,991,479
| – | – | 3.52% | 8 |
|
|
2023
Q1 | $113M | Hold |
5,991,479
| – | – | 3.63% | 9 |
|
|
2022
Q4 | $95.4M | Hold |
5,991,479
| – | – | 2.9% | 10 |
|
|
2022
Q3 | $98M | Hold |
5,991,479
| – | – | 2.89% | 10 |
|
|
2022
Q2 | $84.4M | Hold |
5,991,479
| – | – | 2.91% | 11 |
|
|
2022
Q1 | $145M | Buy |
5,991,479
+2,930,886
| +96% | +$71M | 4.54% | 7 |
|
|
2021
Q4 | $71.4M | Buy |
+3,060,593
| New | +$71.4M | 2.28% | 13 |
|
|
2020
Q3 | – | Sell |
-135,413
| Closed | -$6.56M | – | 45 |
|
|
2020
Q2 | $6.56M | Sell |
135,413
-188,476
| -58% | -$9.13M | 0.48% | 30 |
|
|
2020
Q1 | $13.7M | Sell |
323,889
-176,111
| -35% | -$7.44M | 1.43% | 22 |
|
|
2019
Q4 | $21.4M | Buy |
+500,000
| New | +$21.4M | 1.93% | 17 |
|